Abstract β-Adrenergic signaling regulates many physiological processes in skeletal muscles. A wealth of evidence has shown that β-agonists can increase skeletal muscle mass in vertebrates. Nevertheless, to date, the specific role of β-adrenergic receptors in different cell phenotypes (myoblasts, fibroblasts, and myotubes) and during the different steps of embryonic skeletal muscle differentiation has not been studied. Therefore, here we address this question through the analysis of embryonic chick primary cultures of skeletal muscle cells during the formation of multinucleated myotubes. We used isoproterenol (ISO), a β-adrenergic receptor agonist, to activate the β-adrenergic signaling and quantified several aspects of muscle differentiation. ISO induced an increase in myoblast proliferation, in the percentage of Pax7-positive myoblasts and in the size of skeletal muscle fibers, suggesting that ISO activates a hyperplasic and hypertrophic muscle response. Interestingly, treatment with ISO did not alter the number of fibroblast cells, suggesting that ISO effects are specific to muscle cells in the case of chick myogenic cell culture. We also show that rapamycin, an inhibitor of the mammalian target of rapamycin signaling pathway, did not prevent the effects of ISO on chick muscle fiber size. The collection of these results provides new insights into the role of β-adrenergic signaling during skeletal muscle proliferation and differentiation and specifically in the regulation of skeletal muscle hyperplasia and hypertrophy.
Introduction β-Adrenergic signaling is involved in the regulation of many physiological processes in skeletal muscles (Yang and McElligott, 1989; Lynch and Ryall, 2008) . β-Adrenergic receptors (β-AR) agonists can increase skeletal muscle mass, protein gain, and decrease body fat. Although three β-AR exist (β1, β2, and β3), the β2-AR is the most abundant in skeletal muscle, with a minor β1-AR population. The endogenous catecholamines epinephrine and norepinephrine are the natural agonists of AR (α and β), and several exogenous compounds, such as isoproterenol (ISO), have been synthesized to selectively activate β-AR. To date, the specific roles are not known of β-AR during the different stages of embryonic skeletal myogenesis and in different myogenic cell phenotypes (muscle fibroblasts, myoblasts, and myotubes). Skeletal myogenesis is a multi-step process that involves the replication of presumptive myoblasts, the emergence of post-mitotic myoblasts, the elongation of postmitotic myoblasts into bipolar cells, the intercellular recognition of bipolar myoblasts, myoblast fusion, the formation of multinucleated myotubes containing highly organized sarcomeric structures, and the continued growth of young myotubes into mature fibers (Choi et al., 1990) . Only some of these complex and sequential series of events are observed when immortalized myogenic cell lines are induced to differentiate in vitro. In contrast, all these steps can be observed in detail and in a temporal sequence in primary muscle cell cultures prepared from breast muscles from day-11 chick embryos (Ojima et al., 2016) . The embryonic chick muscle culture is a robust model for studies of the molecular and cellular events that control skeletal muscle differentiation; for example, myotubes containing thousands of nuclei are easily observed in chick primary muscle cultures, compared to the few nuclei observed in myotubes obtained from immortalized muscle cell lines (Mermelstein et al., 2005) .
It has been shown that β-AR first appear during the myoblast fusion stage of embryonic quail myogenesis and that mature myotubes contain~80-fold more receptors per cell than proliferating myoblasts (Parent et al., 1980) . This is consistent with the lesser response chick myoblasts have to ISO compared to myotubes (Curtis and Zalin, 1985) . Interestingly, ISO provokes primary chick myoblasts to initiate precocious cell fusion (Curtis and Zalin, 1981) , and this effect has been associated with the canonical rise in intracellular adenosine 3′,5-monophosphate (cyclic AMP) and the noncanonical Akt/mTOR pathway (Ryall et al., 2010) . Importantly, no further study was dedicated to the analysis of the possible distinct role of β-AR signaling in the different cell phenotypes (fibroblasts, myoblasts and myotubes) that are present during embryonic skeletal muscle differentiation. Thus, the present work aimed to study the effect of the β-AR activity during in vitro chick skeletal myogenesis. We found that ISO, a potent β-AR agonist, induced an increase in myoblast proliferation, in the number of Pax7-positive myoblasts and in the size of myotubes. The collection of our data demonstrates the relevance of the use of β-AR agonists in muscle degeneration diseases.
Materials and methods

Antibodies and probes
DNA-binding probe 4,6-diamino-2-phenylindole dyhydrochloride (DAPI) was purchased from Molecular Probes (USA). The following antibodies were used in this study: anti-sarcomeric alpha-actinin (clone EA53; Sigma, USA), anti-desmin (Sigma), anti-Pax7 (Developmental Studies Hybridoma Bank, USA), Alexa Fluor 488-goat anti-rabbit IgG (Molecular Probes) and Alexa Fluor 546-goat anti-mouse IgG (Molecular Probes).
Cell cultures
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (USA). The protocol was approved by the Institutional Animal Care and Use Committee (Protocol Number: 055/16).
Chick myogenic cultures were prepared as described previously (Ojima et al., 2016) . Cells were plated at an initial density of 5 × 10 5 cells/35 mm dishes in 8-1-0.5 medium (minimum essential medium with 10% horse serum, 0.5% chick embryo extract, 1% L-glutamine, and 1% penicillinstreptomycin) and mantained at 37°C with 5% CO 2 . Twentyfour-hour myogenic chick cultures were treated for 24 or 48 h with either: ISO (Sigma, USA) at 10, 50, and 100 nM; or with 0.1% dimethyl sulfoxide (DMSO), the same DMSO concentration used in 100 nM ISO, or with rapamycin (RAPA; Sigma) at 3 µM, or with Wnt5a-conditioned medium (10% v/v).
Mouse L-cell culture and Wnt5a-conditioned medium preparation L-Wnt5a cells were obtained from American Type Culture Collection (ATCC, USA) and cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) and 0.4 mg/mL neomycin (Invitrogen) to maintain transgene expression during cell culture expansion. Conditioned medium from L-Wnt5a was collected according to the manufacturer's instructions. Activity of the conditioned medium was tested in previous studies of our group (Guerra et al., 2016) . Wnt5a-conditioned medium (10% v/v) were added to 24-h myogenic chick cultures and cells were fixed with 4% paraformaldehyde (in phosphate-buffered saline) after 24 h.
Determination of protein concentration
Chick myogenic cells were plated at an initial density of 5 × 10 5 cells/35 mm culture dishes and incubated at 37°C and 5% CO 2 . Total cell culture extracts were prepared from 48-h untreated and treated (with DMSO or ISO 100 nM) cells scraped off the dish in radioimmunoprecipitation assay buffer buffer (0.15 M NaCl, 1% NP-40, 0.25% sodium deoxicolate, 2 mM ethylenediaminetetraacetic acid, 0.05 M Tris-HCl, pH 67.4) with protease inhibitors. Protein concentration was estimated according to Bradford (1976) . Protein concentration (mean ± standard deviation) was expressed as µg/µL. Experiments were performed in triplicate.
Cell viability assay
Cell viability was determined using 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reagent (Sigma, USA) and as described in detail by Rosa de Andrade et al. (2018) . Cells were plated at an initial density of 10 5 cells per well in 24-well plates and after 24 h some cultures were treated with ISO (10, 50, and 100 nM) for 48 h. Absorbance was measured in a microplate reader (FlexStation Reader; Molecular Devices, USA) at 570 nm.
Immunofluorescence and digital image acquisition
Myogenic cells were fixed and labeled with fluorescently labeled antibodies as described in detail by Possidonio et al. (2014) . Cells were mounted in Prolong (Molecular Probes) and examined with an Axiovert fluorescence microscope (Carl Zeiss, Germany).
Quantification of chick cell cultures
Phase contrast microscopy images of live cultured cells were acquired with an Axiovert 100 microscope (Carl Zeiss). Myogenic cell cultures were quantified using a CellProfiler Analyst (http://cellprofiler.org; Jones et al., 2008) . The DAPI labeling, together with the desmin labeling, enables the identification of myoblasts and fibroblasts by the presence of desmin and by the differences in their nuclear morphologies and fluorescence intensities. The muscle cell area was quantified using Fiji software. The percentage of myoblast cells was calculated by the number of myoblasts divided by the total number of muscle cells (myoblasts + nuclei within myotubes). All data was quantified from 50 randomly chosen microscopic fields collected from three independent experiments.
Statistical analysis
Statistical analysis of data related to the quantification of cell numbers was performed by one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparisons test; and the paired Student t test was used for the quantification of the percentage of Pax7-positive cells; and one-way ANOVA followed by Tukey's post-test for the quantification of the percentage of the area occupied by α-actinin in muscle cells (GraphPad Software, CA, USA). Statistical significance was defined as *P < 0.05; **P < 0.01; ***P < 0.001.
Results and discussion
ISO induces an increase in muscle fiber size acompanied by an increase in protein concentration First, we analyzed the effects of ISO (10, 50, and 100 nM) in cell viability during chick in vitro myogenic differentiation. DMSO (0.1%) or ISO-treated cells did not exhibit loss of viability in all the concentrations tested using an MTT assay (Figure 1) . To investigate the impact of ISO during skeletal muscle differentiation, cells were treated with ISO (50 and 100 nM) for 48 h and live cells analyzed using phase contrast microscopy (Figure 2A-D) . Treatment of muscle cells with ISO for 48 h induced the formation of multinucleated myotubes with increased size compared with untreated and DMSO-treated cells (Figure 2A-D ).
Cells treated with ISO 100 nM for 48 h seem to have myotubes with increased width compared to those with ISO 50 nM (Figure 2A-D) . The increase in the size of myotubes was not observed in cultures treated with ISO for 24 h (data not shown). We also analyzed whether the increase in myotube size was accompanied by an increase in protein synthesis. Protein concentration was determined in samples from 72-h control (CTRL) (untreated) cells and cells treated with DMSO or ISO 100 nM and showed an 20% increase in protein amount in ISO compared with untreated cells (5.0 ± 1.0 µg/µL in CTRL, 4.5 ± 0.5 µg/µL in DMSO and 6.0 ± 0.9 µg/µL in ISO 100 nM; mean ± standard deviation; n = 3).
ISO induces myoblast proliferation and muscle hypertrophy
Next, we decided to explore the effects of ISO in the different cell phenotypes (fibroblasts, myoblasts, and myotubes) that are present in embryonic chick muscle cultures. Twenty-four-hour Chick myogenic cells were treated with ISO (50 and 100 nM) for 48 h, labeled with an anti-desmin antibody (used as a muscle-specific cell marker) and the nuclear dye DAPI, and analyzed under a fluorescence microscope (Figure 3 ). Images were quantified in relation to: area of muscle cells (myoblasts and myotubes), number of myoblasts, number of fibroblasts, number of nuclei within myotubes, and percentage of myoblast cells (number of myoblasts divided by the number of nuclei in muscle cells); all in comparison with untreated cells (Figure 4) . ISO treatment induced an (Ji and Orcutt, 1991; Kumar et al., 2003) , and in rat and mouse myogenic cell cultures (Harper et al., 1990) . Also, our results are in accordance with the data reported by other researchers which showed that feeding of avians and mammalian livestock with β-AR agonists enhances muscle mass (Mersmann, 1998) . In ruminants, the average increase of muscle cross-sectional area is around 11% and 39% (Johnson et al., 2014) . No significant differences were found in the number of muscle fibroblasts after exposure of cells to ISO ( Figure  4D ). Contrasting with our data, it has been shown that ISO induces an increase in rat and human cardiac fibroblast proliferation (Leicht et al., 2000; Turner et al., 2003) , which was reported to be dependent on the presence of fetal calf serum (FCS). Interestingly, the authors describe that ISO did not induce cardiac fibroblast proliferation in serumfree medium (Leicht et al., 2000; Turner et al., 2003) , similar to what was found for human Tenon's capsule fibroblasts (Cunliffe et al., 1995) . We can hypothesize that the differences in proliferation response to ISO between cardiac and skeletal muscle fibroblasts could be due to the fact that primary cultures of chick skeletal muscle cells are grown in the presence of horse serum and without FCS. Indeed, it has been suggested that ISO acts synergistically with other serum-derived factors present in FCS to initiate a mitogenic response in cardiac fibroblasts (Leicht et al., 2000; Turner et al., 2003) . Besides this, the fibroblast proliferative phenotype and response to stimuli have been shown to depend on the muscle type and, possibly, animal species (Archile-Contreras et al., 2010; Purslow et al., 2012) . Further studies are necessary to unravel these questions.
ISO induces an increase in the number of Pax7-positive cells Parent et al. (1980) have shown that β-AR appear during the myoblast fusion stage of myogenesis in primary cultures of skeletal muscle cells obtained from 10-day-old quail embryos. They also reported that quail muscle cells Figure 4 Isoproterenol induces an increase in the number of myoblasts and in the area of muscle cells. Myogenic cells were grown for 24 h and treated with isoproterenol (ISO) (50 or 100 nM) for the next 48 h. Control cells (CTRL) were left untreated. Seventy-two-hour cells were labeled with an anti-desmin antibody and the nuclear dye 4,6-diamino-2-phenylindole dyhydrochloride (DAPI). Images were quantified in relation to: the area of muscle cells (myoblasts and myotubes), number of myoblasts, number of fibroblasts, number of nuclei within myotubes, and percentage of myoblast cells (number of myoblasts divided by the number of nuclei in muscle cells). *P < 0.05, ***P < 0.001; One-way analysis of variance (ANOVA) followed by Dunnett's multiple comparisons test; n = 3. At least 50 microscopic fields for each culture condition were scored in at least three independent experiments.
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Isoproterenol (Parent et al., 1980) . Our results are somehow in contrast with these previous data since we show that 24-h chick myogenic cultures respond to ISO by inducing the proliferation of myoblasts. Primary cultures of chick muscle cells grown for 24-h display different cell phenotypes: fibroblasts, myoblasts, and young myotubes; and more than one population of myoblasts can be found in these cultures, such as quiescent, proliferative, and postmitotic myoblasts. To better understand which myoblast population is responding to ISO, we decided to analyze the effects of ISO in the percentage of Pax7-positive cells ( Figure 5 ). It has been shown that Pax7 is expressed in both quiescent and proliferating myoblasts, but not in differentiated myoblasts (Zammit et al., 2006) . Chick muscle cultures treated with ISO 100 nM showed a threefold increase in the number of Pax7-positive cells ( Figure 5I ). Interestingly, all Pax7-positive cells were found adjacent to the sarcolemma of myotube cells, suggesting that these Pax7-positive cells are in the process of cell fusion ( Figure  5E -H). These results are in accordance with the increase in the number of nuclei within myotubes and in myoblast fusion and indicate a hyperplasic response evoked by ISO (Figure 4 ).
Rapamycin cannot inhibit ISO-induced effects on muscle fiber size
We also decided to test whether the ISO-induced effects on muscle fiber size were mediated by the mammalian target of rapamycin (mTOR) signaling pathway. mTOR is an evolutionarily conserved serine/threonine kinase which plays a vital role in the control of skeletal muscle mass (Yoon, 2017) . Here, we used RAPA, a highly specific inhibitor of mTOR signaling, to test the involvement of the mTOR signaling in chick muscle cell cultures. Twentyfour-hour myogenic cells were treated with ISO 100 nM, or RAPA 3 µM, or with ISO and RAPA concomitantly.
Immunofluorescence against sarcomeric-α-actinin together with the nuclear labeling showed that RAPA alone induced a decrease in myotube size, whereas ISO alone induced an increase in myotube size ( Figure 6 ). Interestingly, when both reagents (ISO and RAPA) were added together, we could observe a similar size of myotubes as compared to ISO alone ( Figure 6 ). These results show that RAPA did not inhibit the increase in myotube size induced by ISO ( Figure  6I ). The reduction in myotube size induced by RAPA alone is in accordance with previous data from different groups and can be explained by the inhibition of the mTOR pathway (Cuenda and Cohen, 1999) . Our results strongly suggest that the ISO-induced effects on chick muscle fiber size are not mediated by the hypertrophic related-mTOR pathway.
ISO can rescue the Wnt5a-induced effects on muscle fiber size Finally, we decided to test whether the Wnt5a-mediated signaling pathway could be involved in the increase in myofiber size induced by ISO. Wnt5a is a noncanonical Wnt ligand that is evolutionarily conserved and plays an important role in the early phase of muscle regeneration Maltzahn et al., 2012) . Previous data from our group showed that Wnt5a inhibits the formation of chick muscle fibers (Portilho et al., 2007) , and therefore we hypothesized that Wnt5a could inhibit the effects of ISO in relation to the size of muscle fibers. Twenty-four-hour myogenic cells were treated with ISO 100 nM, or Wnt5a-conditioned medium (10% v/v), or with ISO and Wnt5a concomitantly and labeled for desmin. Our results show that Wnt5a alone induced an evident decrease in myotube size ( Figure  7D-F) , which is in accordance with previous data from our group (Portilho et al., 2007) . Interestingly, ISO and Wnt5a added together induced an increase in the number and size of muscle fibers ( Figure 7J-L) , showing that Wnt5a did not inhibit the effects of ISO in myotube size. These results lead us to conclude that Wnt5a signaling pathway is not involved in the hypertrophic events induced by ISO in chick skeletal muscle cells.
In conclusion, here we show that the β-adrenergic receptor agonist ISO induces an increase in myoblast proliferation, in the percentage of Pax7-positive myoblasts and in the size of skeletal muscle fibers. Interestingly, treatment with ISO did not alter the number of fibroblast cells, suggesting that ISO effects are specific to muscle cells in the case of chick myogenic cell culture. We also showed that the ISO-induced effects on chick muscle fiber size are not mediated by the mTOR or the Wnt5a signaling pathways.
Finally, in relation to protein concentration, we found that its increase after ISO treatment was lower than the increase in the number of nuclei in the myotubes (20% and 50%, respectively), a fact supporting a hyperplasic process. Although hypertrophy and hyperplasia are two distinct processes, they frequently occur together. Thus, we suggest that ISO induces first the proliferation of Pax7-positive cells and subsequently some of these cells will fuse into multinucleated muscle fibers with increased size and increased protein synthesis. The collection of these results provides new insights into the role of β-adrenergic signaling during skeletal muscle proliferation and differentiation. Figure 6 Rapamycin does not inhibit the effects of isoproterenol. Myogenic cells were grown for 24 h and treated with isoproterenol (ISO) 100 nM, or rapamycin 3 µM (RAPA), or with ISO and RAPA concomitantly for the next 48 h (A-H). Control cells were left untreated (A-B). Seventy-two-hour cells were labeled with an anti-sarcomericalpha-actinin monoclonal antibody (red; A, C, E and G) and the nuclear dye 4,6-diamino-2-phenylindole dyhydrochloride (DAPI) (blue; B, D, F and H). Note the decrease in the size of myotubes when cells were treated with RAPA (E and F). Scale bar in B represents 100 μm. *P < 0.05, One-way analysis of variance (ANOVA) followed by Tukey's post-test, n = 3. At least 50 microscopic fields for each culture condition were scored in at least three independent experiments. 
Acknowledgments and funding
